Business Segments · Depreciation
Diagnostics — Depreciation
Labcorp Holdings Diagnostics — Depreciation decreased by 2.3% to $63.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $61.70M to $63.80M. Over 4 years (FY 2021 to FY 2025), Diagnostics — Depreciation shows relatively stable performance with a 2.1% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026
Rolls up toD&A
How to read this metric
High depreciation relative to revenue may indicate a capital-intensive business model or recent heavy investment in new technology, while low depreciation may suggest aging infrastructure.
Detailed definition
This reflects the systematic allocation of the cost of tangible assets, such as laboratory equipment, testing machinery,...
Peer comparison
Commonly analyzed alongside capital expenditure to assess the age and maintenance of the asset base.
Metric ID:
lh_segment_diagnostics_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.65M | $59.65M | $59.65M | $56.78M | $56.78M | $56.78M | $56.78M | $59.03M | $59.03M | $59.03M | $59.03M | $61.70M | $63.10M | $65.10M | $69.10M | $61.70M | $65.40M | $66.40M | $65.30M | $63.80M |
| QoQ Change | — | +0.0% | +0.0% | -4.8% | +0.0% | +0.0% | +0.0% | +4.0% | +0.0% | +0.0% | +0.0% | +4.5% | +2.3% | +3.2% | +6.1% | -10.7% | +6.0% | +1.5% | -1.7% | -2.3% |
| YoY Change | — | — | — | — | -4.8% | -4.8% | -4.8% | +4.0% | +4.0% | +4.0% | +4.0% | +4.5% | +6.9% | +10.3% | +17.1% | +0.0% | +3.6% | +2.0% | -5.5% | +3.4% |
Range$56.78M – $69.10M
CAGR+1.4%
Avg YoY Growth+2.7%
Median YoY Growth+3.8%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's diagnostics — depreciation?
- Labcorp Holdings (LH) reported diagnostics — depreciation of $63.80M in Q1 2026.
- How has Labcorp Holdings's diagnostics — depreciation changed year-over-year?
- Labcorp Holdings's diagnostics — depreciation increased by 3.4% year-over-year, from $61.70M to $63.80M.
- What is the long-term trend for Labcorp Holdings's diagnostics — depreciation?
- Over 4 years (2021 to 2025), Labcorp Holdings's diagnostics — depreciation has grown at a 2.1% compound annual growth rate (CAGR), from $238.60M to $258.80M.
- What does diagnostics — depreciation mean?
- The annual non-cash expense for the wear and tear of diagnostic equipment and facilities.